<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04053998</url>
  </required_header>
  <id_info>
    <org_study_id>WB-08-2019</org_study_id>
    <nct_id>NCT04053998</nct_id>
  </id_info>
  <brief_title>Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org</brief_title>
  <official_title>Benchmarking Outcomes in Pancreatoduodenectomy With Portal Vein Resection - WhippleBenchmarks.Org</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Free Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Institute Hospital, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Curry Cabral, CHLC, Lisbon, Portugal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Joseph's Hospital of Atlanta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Italiano de Buenos Aires</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Juntendo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Elizabeth Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes University Hospital, Rennes, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Raffaele University Hospital, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Vincent's University Hospital, Dublin, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mainz University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria Integrata Verona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Zürich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Free Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The WhippleBenchmark 2 Collaborative study aims at defining benchmark criteria for best
      achievable outcomes after pancreaticoduodenectomy with portal vein resection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreatoduodenectomy (PD) with portal vein resection (PVR) is performed for the achievement
      of complete resection (R0) in patients with locally advanced pancreatic head lesions. Despite
      most commonly performed in high-volume pancreatic surgery centers by experienced surgeons,
      best achievable outcomes, such as morbidity and mortality, following such complex procedure
      remain unknown.

      The aim is to conduct a retrospective multicenter cohort study to define benchmark values for
      best achievable outcomes following duodenopancreatectomy (DP) with portal vein resection
      (PVR).

      Data collection and study design are based on to the well established standardized reporting
      for benchmarking (Sánchez-Velázquez et. al. Ann Surg, February 2019 ).

      This multicenter cohort study will include all consecutive pancreaticoduodenectomies with
      portal vein resections from at least 20 high volume centers performing over 50 pancreatic
      operations per year or 150 cases within 3 years from at least 3 continents over a period of
      10 years (2009-2019). Every center included in the study must have a prospective database
      from which data can be collected as well as previous publications critically reporting on
      their outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>12 months</time_frame>
    <description>Death due to any cause postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity rate</measure>
    <time_frame>12 months</time_frame>
    <description>Classified according to the Clavien-Dindo Classification of postoperative complications.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity assessed according to the Comprehensive Complications Index® (CCI®)</measure>
    <time_frame>12 months</time_frame>
    <description>The Comprehensive Complications Index® (CCI®) reports the cumulative postoperative morbidity, a novel metric which measures the overall morbidity on a scale from 0 (no complications) to 100 (death).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pancreatic fistula rates</measure>
    <time_frame>12 months</time_frame>
    <description>reported according to both the International Study Group of Pancreatic Fistula (ISGPF) and Clavien-Dindo classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission rate</measure>
    <time_frame>12 months</time_frame>
    <description>Any hospital readmission to the primary or other peripheral hospitals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival rate</measure>
    <time_frame>Up to 10 years postoperatively</time_frame>
    <description>Disease recurrence</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pancreatic Neoplasms</condition>
  <condition>Pancreaticoduodenectomy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreaticoduodenectomy with portal vein resection</intervention_name>
    <description>Pancreatic surgery with vein resection to achieve disease clearance.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pancreatic malignancy that underwent open pancreaticoduodenectomy with portal
        vein resection.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Center Eligibility Criteria

          -  High volume centers from ≥3 continents

          -  Minimum 50 cases of pancreatic surgery per year or 150 cases within 3 years

          -  Published in the area of pancreas surgery

          -  Prospective database available

        Patient Eligibility Criteria

        Inclusion Criteria:

          -  Adults ≥ 18 years

          -  Resectable malignant or benign diseases (i.e. all indications)

          -  Open pancreaticoduodenectomy (all techniques allowed) with concurrent portal vein
             resection

        Exclusion Criteria:

          -  Patients &lt; 18 years

          -  Pancreatic resections other than pancreaticoduodenectomy and portal vein resection

          -  Pancreaticoduodenectomy with arterial reconstruction

          -  Laparoscopic or robotic pancreaticoduodenectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe K Fusai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Free Hospital, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dimitri A Raptis, MD, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Free Hospital, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patricia Sánchez Velázquez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Parc de Salut Mar, Barcelona, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nikolaos Machairas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Free Hospital, London, UK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe K Fusai, MD</last_name>
    <phone>00442037582000</phone>
    <email>g.fusai@ucl.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dimitri A Raptis, MD, MSc, PhD</last_name>
    <phone>00447584560889</phone>
    <email>dimitri.raptis@nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Parc de Salut Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Sánchez Velázquez, MD, PhD</last_name>
      <phone>0034932483000</phone>
      <email>PSanchezVelazquez@parcdesalutmar.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe K Fusai, MD</last_name>
      <phone>00442037582000</phone>
      <email>g.fusai@ucl.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Dimitri A Raptis, MD, MS, PhD</last_name>
      <phone>00447584560889</phone>
      <email>dimitri.raptis@nhs.net</email>
    </contact_backup>
    <investigator>
      <last_name>Nikolaos Machairas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://WhippleBenchmarks.org</url>
    <description>The official WhippleBenchmarks.org Study data entry management system</description>
  </link>
  <link>
    <url>https://rBiostatistics.com</url>
    <description>rBiostatistics.com - Cloud Graphical User Interface for R Statistics and eLearning Platform</description>
  </link>
  <link>
    <url>https://www.assessurgery.com</url>
    <description>The Comprehensive Complications Index® (CCI®)</description>
  </link>
  <reference>
    <citation>Sánchez-Velázquez P, Muller X, Malleo G, Park JS, Hwang HK, Napoli N, Javed AA, Inoue Y, Beghdadi N, Kalisvaart M, Vigia E, Walsh CD, Lovasik B, Busquets J, Scandavini C, Robin F, Yoshitomi H, Mackay TM, Busch OR, Hartog H, Heinrich S, Gleisner A, Perinel J, Passeri M, Lluis N, Raptis DA, Tschuor C, Oberkofler CE, DeOliveira ML, Petrowsky H, Martinie J, Asbun H, Adham M, Schulick R, Lang H, Koerkamp BG, Besselink MG, Han HS, Miyazaki M, Ferrone CR, Fernández-Del Castillo C, Lillemoe KD, Sulpice L, Boudjema K, Del Chiaro M, Fabregat J, Kooby DA, Allen P, Lavu H, Yeo CJ, Barroso E, Roberts K, Muiesan P, Sauvanet A, Saiura A, Wolfgang CL, Cameron JL, Boggi U, Yoon DS, Bassi C, Puhan MA, Clavien PA. Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. Ann Surg. 2019 Aug;270(2):211-218. doi: 10.1097/SLA.0000000000003223.</citation>
    <PMID>30829701</PMID>
  </reference>
  <reference>
    <citation>Raptis DA, Mettler T, Fischer MA, Patak M, Lesurtel M, Eshmuminov D, de Rougemont O, Graf R, Clavien PA, Breitenstein S. Managing multicentre clinical trials with open source. Inform Health Soc Care. 2014 Mar;39(2):67-80. doi: 10.3109/17538157.2013.812647.</citation>
    <PMID>24517456</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 9, 2019</study_first_submitted>
  <study_first_submitted_qc>August 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Royal Free Hospital NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Dimitri Raptis</investigator_full_name>
    <investigator_title>Senior Clinical Fellow in HPB and Transplant Surgery</investigator_title>
  </responsible_party>
  <keyword>Pancreaticoduodenectomy</keyword>
  <keyword>Portal vein resection</keyword>
  <keyword>Benchmarks</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The study Investigators will act as the custodians of the data. The data however belong to all collaborators. The study investigators will decide after the publication of the main report about requests from the collaborators regarding secondary analyses and will consider all such requests based on quality and the validity of the proposed project.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The data will remain available to share with the collaborators as described above up to 5 years after the study completion.</ipd_time_frame>
    <ipd_access_criteria>Quality and validity of the proposed project.</ipd_access_criteria>
    <ipd_url>https://whipplebenchmarks.org</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

